CRISPR Therapeutics AG (CRSP) › Total AssetsCRISPR Therapeutics AG (CRSP) — Total AssetsAnnual figures by fiscal year, from SEC filings.2015: $159.42M2016: $344.96M2017: $271.35M2018: $489.02M2019: $1.07B2020: $1.83B2021: $2.75B2022: $2.24B2023: $2.23B2024: $2.24B2025: $2.27B$2.27B2015Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$2.27B+1.0%2024$2.24B+0.6%2023$2.23B-0.6%2022$2.24B-18.5%2021$2.75B+50.5%2020$1.83B+71.4%2019$1.07B+118.1%2018$489.02M+80.2%2017$271.35M-21.3%2016$344.96M+116.4%2015$159.42M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share